Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Szafranski

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nucleus (Austin, Tex.)|March 19, 2014
The fine line between lifespan extension and shortening in response to caloric restrictionKirk Szafranski, Karim Mekhail
Frontiers in Genetics|March 26, 2015
Non-coding RNA in neural function, disease, and agingKirk Szafranski, Karan J Abraham, Karim Mekhail
Journal of Managed Care & Specialty Pharmacy|August 7, 2024
Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to MedicaidJerry Frank, Daniel Son, Kirk Szafranski, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspectiveStefano Del Prato, Francesco Giorgino, Kirk Szafranski, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer PerspectiveStewart Harris, Sal Cimino, Yen Nguyen, et al.
Journal of Medical Economics|December 18, 2020
Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaRima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2025
Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare SystemPeter van Dijk, Chris Chesters, Jack Timmons, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia BRobert Klamroth, Ashley Bonner, Keith Gomez, et al.
Journal of Medical Economics|March 6, 2019
The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaRima Aziziyeh, Mo Amin, Mohdhar Habib, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2024
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative ValidationKirk Szafranski, Gerard De Pouvourville, Dan Greenberg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nucleus (Austin, Tex.)|March 19, 2014
The fine line between lifespan extension and shortening in response to caloric restrictionKirk Szafranski, Karim Mekhail
Frontiers in Genetics|March 26, 2015
Non-coding RNA in neural function, disease, and agingKirk Szafranski, Karan J Abraham, Karim Mekhail
Journal of Managed Care & Specialty Pharmacy|August 7, 2024
Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to MedicaidJerry Frank, Daniel Son, Kirk Szafranski, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspectiveStefano Del Prato, Francesco Giorgino, Kirk Szafranski, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer PerspectiveStewart Harris, Sal Cimino, Yen Nguyen, et al.
Journal of Medical Economics|December 18, 2020
Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaRima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2025
Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare SystemPeter van Dijk, Chris Chesters, Jack Timmons, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia BRobert Klamroth, Ashley Bonner, Keith Gomez, et al.
Journal of Medical Economics|March 6, 2019
The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaRima Aziziyeh, Mo Amin, Mohdhar Habib, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2024
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative ValidationKirk Szafranski, Gerard De Pouvourville, Dan Greenberg, et al.
Pageof 2